Johnson & Johnson
FDA, companies to study metal-on-metal implant effects
- Mon, 07/02/2012 - 4:06pm
The FDA recently asked a panel of experts to recommend guidelines for monitoring over 500,000 patients with metal-on-metal hip replacements.
Johnson & Johnson ignored FDA demand
- Wed, 06/27/2012 - 10:11am
Johnson & Johnson sold its Gynecare Prolift vaginal mesh implant for nine months after the Food and Drug Administration ordered the implant to be taken off the market, Bloomberg News reported y